Majestic Gold Corp. - MJS.V

MJS.V Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
MJS.V	0	-6.2	-6.2	15.4	7.1	-16.7	25	66.7	150	-95
S&P 500	0.4	-1.6	0.5	5.1	11.1	29.6	25.5	88.9	187.7	33272.7

Compare MJS.V with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	MJS.V
name	Majestic Gold Corp.
price	0.07
changes percentage	0
change	0
day low	0.07
day high	0.07
year high	0.10
year low	0.06
market cap	78199500
price avg 50	0.08
price avg 200	0.07
exchange	TSXV
volume	66000
avg volume	868717
open	0.07
previous close	0.08
eps	0.02
pe	3.75
earnings announcement	2024-11-26T00:00:00.000+0000
shares outstanding	1042660000
timestamp	2024-11-18 16:33:25

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.7%

Overall Quarterly Financial Health: 73.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	55025192	63474357	-13.31
gross profit	26572295	33881688	-21.57
gross profit ratio	0.48	0.53	-9.53
research and development expenses	1191540	1443745	-17.47
operating expenses	15920530	6122448	160.04
interest income	1237678	575967	114.89
interest expense	357197	344607	3.65
ebitda	26353005	35190093	-25.11
ebitdaratio	0.48	0.55	-13.61
operating income	18831245	27857441	-32.40
operating income ratio	0.34	0.44	-22.02
net income	7557829	17422560	-56.62
net income ratio	0.14	0.27	-49.96
eps	0.01	0.02	-56.89

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 55 million in 2023 from 63 million in 2022 representing a change of -13.31%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 27 million in 2023 from 34 million in 2022 representing a change of -21.57%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1 million in 2023 from 1 million in 2022 representing a change of -17.47%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 26 million in 2023 from 35 million in 2022 representing a change of -25.11%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 19 million in 2023 from 28 million in 2022 representing a change of -32.4%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 0.01 in 2023 from 0.01 in 2022 representing a change of -56.89%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 16 million in 2023 from 6 million in 2022 representing a change of 160.04%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 8 million in 2023 from 17 million in 2022 representing a change of -56.62%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	18053618	15563660	16.00
gross profit	9764514	8286017	17.84
gross profit ratio	0.54	0.53	1.59
research and development expenses	284598	257484	10.53
operating expenses	4174278	1630444	156.02
interest income	684176	642020	6.57
interest expense	75965	76114	-0.20
ebitda	11076754	9287308	19.27
ebitdaratio	0.61	0.59	3.26
operating income	8195755	6678410	22.72
operating income ratio	0.45	0.43	5.79
net income	2894223	2640441	9.61
net income ratio	0.16	0.17	-5.51
eps	0.0	0.0	12.00

Overall Score of Quarterly Income Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 18 million in 2024Q2 from 16 million in 2024Q1 representing a change of 16.0%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 10 million in 2024Q2 from 8 million in 2024Q1 representing a change of 17.84%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 10.53%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 8 million in 2024Q2 from 7 million in 2024Q1 representing a change of 22.72%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3 million in 2024Q2 from 3 million in 2024Q1 representing a change of 9.61%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 4 million in 2024Q2 from 2 million in 2024Q1 representing a change of 156.02%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 11 million in 2024Q2 from 9 million in 2024Q1 representing a change of 19.27%. The decrease in EBITDA indicates declined operational efficiency and profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	187230603	139605949	34.11
total liabilities	34929238	30272545	15.38
total equity	152301365	109333404	39.30
cash and cash equivalents	15206190	4931645	208.34
short term investments	0	7383000	-100.00
long term investments	0	0	NaN
total current assets	102329936	57437394	78.16
total non current assets	84900667	82168555	3.33
total current liabilities	25873002	21059237	22.86
total non current liabilities	9056236	9213308	-1.70
common stock	122763213	122763213	0.00
retained earnings	-27200323	-45531304	40.26
total debt	4291030	4384652	-2.14

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 187 million in 2023 from 140 million in 2022 representing a change of 34.11%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 152 million in 2023 from 109 million in 2022 representing a change of 39.3%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 15 million in 2023 from 5 million in 2022 representing a change of 208.34%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 102 million in 2023 from 57 million in 2022 representing a change of 78.16%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to -27 million in 2023 from -46 million in 2022 representing a change of 40.26%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 4 million in 2023 from 4 million in 2022 representing a change of -2.14%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 35 million in 2023 from 30 million in 2022 representing a change of 15.38%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 7 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 26 million in 2023 from 21 million in 2022 representing a change of 22.86%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	195106193	188314992	3.61
total liabilities	32861335	31446109	4.50
total equity	162244858	156868883	3.43
cash and cash equivalents	44717825	45301464	-1.29
short term investments	59214932	0	NaN
long term investments	182650	0	NaN
total current assets	109729688	103667654	5.85
total non current assets	85376505	84647338	0.86
total current liabilities	23437646	22438755	4.45
total non current liabilities	9423689	9007354	4.62
common stock	122763213	122763213	0.00
retained earnings	-22880386	-25184108	9.15
total debt	4250905	4276277	-0.59

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 195 million in 2024Q2 from 188 million in 2024Q1 representing a change of 3.61%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 162 million in 2024Q2 from 157 million in 2024Q1 representing a change of 3.43%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 59 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 110 million in 2024Q2 from 104 million in 2024Q1 representing a change of 5.85%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to -23 million in 2024Q2 from -25 million in 2024Q1 representing a change of 9.15%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 4 million in 2024Q2 from 4 million in 2024Q1 representing a change of -0.59%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 33 million in 2024Q2 from 31 million in 2024Q1 representing a change of 4.5%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 45 million in 2024Q2 from 45 million in 2024Q1 representing a change of -1.29%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 23 million in 2024Q2 from 22 million in 2024Q1 representing a change of 4.45%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	52608919	10494715	401.29
operating cash flow	24489794	30285213	-19.14
free cash flow	13671906	22851659	-40.17
capital expenditure	-10817888	-7433554	-45.53
depreciation and amortization	0	0	NaN
deferred income tax	7206030	9239459	-22.01
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	-449045	168124	-367.09
acquisitions net	0	0	NaN
investments in property plant and equipment	-10817888	-7433554	-45.53
net cash used for investing activites	-3666134	-15103198	75.73
debt repayment	0	0	NaN
common stock issued	35232922	0	NaN
common stock repurchased	0	-36538	100.00
dividends paid	0	0	NaN
net cash used provided by financing activities	32035138	-1483083	2,260.04
cash at end of period	97971465	45362546	115.97
accounts receivables	-840643	0	NaN
cash at beginning of period	45362546	34867831	30.10

Overall Score of Annual Cashflow Statement

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 53 million in 2023 from 10 million in 2022 representing a change of 401.29%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -11 million in 2023 from -7 million in 2022 representing a change of -45.53%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -1 million in 2023 from 0 million in 2022 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 24 million in 2023 from 30 million in 2022 representing a change of -19.14%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 14 million in 2023 from 23 million in 2022 representing a change of -40.17%. This indicates a decrease in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	10222541	1380146	640.69
free cash flow	7212581	37063	19,360.33
capital expenditure	-3009960	-1343083	-124.11
depreciation and amortization	0	0	NaN
deferred income tax	2916339	2120560	37.53
stock based compensation	0	0	NaN
accounts receivables	-40579	0	NaN
accounts payables	0	0	NaN
inventory	522660	115899	350.96
acquisitions net	0	0	NaN
investments in property plant and equipment	-3009960	-1343083	-124.11
net cash used for investing activites	-3424344	-1344452	-154.70
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-44181	-44348	0.38
net change in cash	6442484	-481192	1,438.86
cash at end of period	103932757	97490273	6.61
cash at beginning of period	97490273	97971465	-0.49

Overall Score of Quarterly Cashflow Statement

0.83 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 6 million in 2024Q2 from 0 million in 2024Q1 representing a change of 1438.86%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 10 million in 2024Q2 from 1 million in 2024Q1 representing a change of 640.69%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 7 million in 2024Q2 from 0 million in 2024Q1 representing a change of 19360.33%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -3 million in 2024Q2 from -1 million in 2024Q1 representing a change of -124.11%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 3 million in 2024Q2 from 2 million in 2024Q1 representing a change of 37.53%. This indicates that the company's tax liability for future periods has increased.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.05	0.06	-13.31
net income per share	0.01	0.02	-56.62
operating cash flow per share	0.02	0.03	-19.14
free cash flow per share	0.01	0.02	-40.17
cash per share	0.01	0.01	23.48
book value per share	0.15	0.1	39.29
tangible book value per share	0.15	0.1	39.29
shareholders equity per share	0.1	0.08	21.47
interest debt per share	0.0	0.0	-1.28
market cap	55029608.17	76920655.91	-28.46
enterprise value	44114448.17	76373662.91	-42.24
pe ratio	7.28	4.42	64.92
price to sales ratio	1.0	1.21	-17.47
pocfratio	2.25	2.54	-11.53
pfcf ratio	4.03	3.37	19.58
pb ratio	0.52	0.88	-41.11
ptb ratio	0.52	0.88	-41.11
ev to sales	0.8	1.2	-33.37
enterprise value over ebitda	1.67	2.17	-22.87
ev to operating cash flow	1.8	2.52	-28.57
ev to free cash flow	3.23	3.34	-3.46
earnings yield	0.14	0.23	-39.36
free cash flow yield	0.25	0.3	-16.37
debt to equity	0.04	0.05	-19.05
debt to assets	0.02	0.03	-26.68
net debt to ebitda	-0.41	-0.02	-2,564.64
current ratio	3.96	2.73	45.01
interest coverage	52.72	80.84	-34.78
income quality	2.0	1.74	15.20
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.14	0.07	111.45
research and ddevelopement to revenue	0.02	0.02	-4.80
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.44	0.25	79.97
capex to revenue	0.2	0.12	67.87
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.13	0.18	-27.41
roic	0.11	0.2	-45.93
return on tangible assets	0.04	0.12	-67.65
graham net net	-0.02	-0.02	-4.76
working capital	76456934	36378157	110.17
tangible asset value	152301365	109333404	39.30
net current asset value	67400698	27164849	148.12
invested capital	157165502	114235417	37.58
average receivables	515159	136350	277.82
average payables	5587998.5	5397848.5	3.52
average inventory	2879485.5	2890921.5	-0.40
days sales outstanding	6.83	0	NaN
days payables outstanding	80.5	60.45	33.18
days of inventory on hand	39.52	33.03	19.64
receivables turnover	53.41	0	NaN
payables turnover	4.53	6.04	-24.91
inventory turnover	9.24	11.05	-16.42
roe	0.07	0.2	-64.29
capex per share	0.01	0.01	45.52

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 7.28 on 2023-12-31 from 4.42 on 2022-12-31, representing a change of 64.92%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2023-12-31 from 0.05 on 2022-12-31, representing a change of -19.05%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  Current Ratio: Current Ratio increased to 3.96 on 2023-12-31 from 2.73 on 2022-12-31, representing a change of 45.01%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
MJS.V
calendar year	2024	2024	NaN
revenue per share	0.02	0.01	15.97
net income per share	0.0	0.0	9.58
operating cash flow per share	0.01	0.0	640.47
free cash flow per share	0.01	0.0	19,354.75
cash per share	0.1	0.04	129.36
book value per share	0.16	0.15	3.40
tangible book value per share	0.16	0.15	3.40
shareholders equity per share	0.11	0.1	2.22
interest debt per share	0.0	0.0	-0.47
market cap	45770650.51	49908173.26	-8.29
enterprise value	5303730.51	8882986.26	-40.29
pe ratio	3.95	4.73	-16.33
price to sales ratio	2.54	3.21	-20.94
pocfratio	4.48	36.16	-87.62
pfcf ratio	6.35	1346.58	-99.53
pb ratio	0.42	0.46	-10.31
ptb ratio	0.42	0.46	-10.31
ev to sales	0.29	0.57	-48.53
enterprise value over ebitda	0.48	0.96	-49.94
ev to operating cash flow	0.52	6.44	-91.94
ev to free cash flow	0.74	239.67	-99.69
earnings yield	0.06	0.05	19.52
free cash flow yield	0.16	0.0	21,119.48
debt to equity	0.04	0.04	-2.64
debt to assets	0.02	0.02	-3.91
net debt to ebitda	-3.65	-4.42	17.30
current ratio	4.68	4.62	1.34
interest coverage	107.89	87.74	22.96
income quality	1.72	0.27	540.13
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.09	0.08	8.11
research and ddevelopement to revenue	0.02	0.02	-4.71
intangibles to total assets	0	0	NaN
capex to operating cash flow	0.29	0.97	-69.74
capex to revenue	0.17	0.09	93.20
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.08	0.08	5.84
roic	0.05	0.04	13.87
return on tangible assets	0.01	0.01	5.80
graham net net	0.07	0.01	371.86
working capital	86292042	81228899	6.23
tangible asset value	162244858	156868883	3.43
net current asset value	76868353	72221545	6.43
invested capital	166766239	161348776	3.36
average receivables	0	515159	-100.00
average payables	4390215.5	5252266.5	-16.41
average inventory	2789879	3020159.5	-7.62
days sales outstanding	0	0	NaN
days payables outstanding	49.41	52.3	-5.52
days of inventory on hand	28.45	36.6	-22.27
receivables turnover	0	0	NaN
payables turnover	1.82	1.72	5.84
inventory turnover	3.16	2.46	28.64
roe	0.03	0.02	7.20
capex per share	0.0	0.0	124.04

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 7.20%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 3.95 on 2024-06-30 Q2 from 4.73 on 2024-03-31 Q1, representing a change of -16.33%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 4.68 on 2024-06-30 Q2 from 4.62 on 2024-03-31 Q1, representing a change of 1.34%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of -2.64%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None